Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, Liver Glycogen synthase activity, and β-oxidation in fructose-fed rats

This publication has 22 references indexed in Scilit:

• Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance
  Diabetes Research and Clinical Practice, 1994
• Effect of Gemfibrozil Treatment in Sulfonylurea-Treated Patients with Noninsulin-Dependent Diabetes Mellitus*
  Journal of Clinical Endocrinology & Metabolism, 1991
• In vitro studies on the action of CS-045, a new antidiabetic agent
  Metabolism, 1990
• Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study
  Diabetes Care, 1988
• Mechanism of insulin resistance in fructose-fed rats
  Metabolism, 1982
• Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: Heterogeneity monooxygenase responses
  Pharmacological Research Communications, 1981
• Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
• Induction of hyperglyceridemia by fructose in the rat
  Life Sciences, 1965
• Liquid scintillation counting of C14O2 with phenethylamine
  Analytical Biochemistry, 1961
• Colorimetric Method for Determination of Sugars and Related Substances
  Analytical Chemistry, 1956